Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update

被引:83
作者
Elnashar, Aboubakr M. [1 ]
机构
[1] Benha Univ, Dept Obstet & Gynecol, Banha, Egypt
关键词
Progesterone rise; Premature luteinization; IVF; IN-VITRO FERTILIZATION; HUMAN CHORIONIC-GONADOTROPIN; ELEVATED SERUM PROGESTERONE; INTRACYTOPLASMIC SPERM INJECTION; LATE FOLLICULAR PHASE; CONTROLLED OVARIAN HYPERSTIMULATION; HORMONE ANTAGONIST CETRORELIX; HIGHER PREGNANCY RATE; INVITRO FERTILIZATION; EMBRYO TRANSFER;
D O I
10.1007/s10815-010-9393-8
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Premature luteinization (PL) refers to a rise in serum progesterone (P) levels on the day of hCG administration. Most studies used an absolute P level on the day of hCG administration as an indicator of PL, and the cutoff level differed from 0.8 to 2 ng/mL. Some authors defined PL as a P/E2 ratio of > 1. There is a marked variation in the incidence (13% to 71%), of PL due to discrepancies in definition, population characteristics and/or treatment protocols. The pathogenesis of PL in COH is still poorly understood. Several hypotheses may be considered to explain this phenomenon: elevation of follicular LH levels, serum accumulation of HCG from HMG, increased LH receptor sensitivity of the granulosa cells to FSH, or poor ovarian response with increased LH sensitivity. The consequences of this premature elevation of serum P on IVF outcome remain controversial. Attempts to prevent COH include: use of Low-dose hCG alone in the late COH stages, flexible antagonist protocol, use of mifepristone, aspiration of a single leading follicle, hCG administration when the levels of serum P exceeded 1.0 ng/mL.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 69 条
[1]
Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer [J].
Abuzeid, MI ;
Sasy, MA .
FERTILITY AND STERILITY, 1996, 65 (05) :981-985
[2]
Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone [J].
Adonakis, G ;
Deshpande, N ;
Yates, RWS ;
Fleming, R .
FERTILITY AND STERILITY, 1998, 69 (03) :450-453
[3]
Antoine J. M., 1992, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V21, P629
[4]
BARASH A, 1990, FERTIL STERIL, V53, P865
[5]
BENNUN I, 1990, FERTIL STERIL, V53, P276
[6]
Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome [J].
Bosch, E ;
Valencia, W ;
Escudero, E ;
Crespo, J ;
Simón, C ;
Remohi, J ;
Pellicer, A .
FERTILITY AND STERILITY, 2003, 80 (06) :1444-1449
[7]
Comment on: Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis [J].
Bosch, Ernesto .
HUMAN REPRODUCTION UPDATE, 2008, 14 (02) :194-195
[8]
SERUM PROGESTERONE CONCENTRATIONS ON THE DAY AFTER HUMAN CHORIONIC-GONADOTROPIN ADMINISTRATION AND PROGESTERONE OOCYTE RATIOS PREDICT IN-VITRO FERTILIZATION-EMBRYO TRANSFER OUTCOME [J].
BURNS, WN ;
WITZ, CA ;
KLEIN, NA ;
SILVERBERG, KM ;
SCHENKEN, RS .
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1994, 11 (01) :17-23
[9]
Serum progesterone at the time of human chorionic gonadotrophin does not predict pregnancy in in-vitro fertilization and embryo transfer [J].
Bustillo, M ;
Stern, JJ ;
Coulam, CB .
HUMAN REPRODUCTION, 1995, 10 (11) :2862-2867
[10]
Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure [J].
Chand, Ashwini L. ;
Ponnampalam, Anna P. ;
Harris, Sarah E. ;
Winship, Ingrid M. ;
Shelling, Andrew N. .
FERTILITY AND STERILITY, 2006, 86 (04) :1009-1012